アストラ接種した人たちと一般の人たちとで血栓発生率に違いはない、と

ノルウェー・デンマーク・アイスランドがAstraZenecaのワクチンの使用を中止https://t.co/muLI6VDFsu　有効率の低さが問題なのかと思ったら血餅と関連したリスクが原因。EUとしては安全と判断としている。

— Spica (@Kelangdbn) March 11, 2021

アストラに関しては欧州で恐怖を煽っていたからねえ。 

Denmark, Norway suspend AstraZeneca vaccine over blood clot fears 

Use of vaccine paused for 14 days in Denmark while investigators probe reports of possible ‘serious side-effects’.

 11 Mar 2021

 The European Union’s drug regulator, the European Medicines Agency (EMA), said on Wednesday there was no evidence so far linking AstraZeneca to the two cases in Austria.

It said the number of thromboembolic events – marked by the formation of blood clots – in people who have received the AstraZeneca vaccine is no higher than that seen in the general population, with 22 cases of such events being reported among the three million people who have received it as of March 9.

アストラ接種した人たちと一般の人たちとで血栓発生率に違いはない、と。